Indiana University-Purdue University Indianapolis (IUPUI) / Ends of linear chromosomes are maintained by specialized structures known as telomeres. These structures are protected by a number of essential protein complexes including the shelterin complex and CST (CTC1 – STN1 – TEN1) complex. CST is an RPA-like ssDNA binding protein that is vital for telomere length maintenance via inhibition of telomerase and stimulation of DNA polymerase α -primase during C-strand fill-in synthesis. CST is also known to possess additional genome-wide roles in regulating DNA replication and repair including helping facilitate replication re-start at stalled forks, activating checkpoint signaling at double-strand breaks, and promoting replication origin firing. Proper and efficient repair of DNA is critical in order to protect the integrity of the genome and prevent extreme mutagenesis. Telomeres have a strong predisposition to oxidative DNA damage in the form of 8-oxoguanine caused by exposure to reactive oxygen species and free radicals. These oxidative lesions are repaired by the base-excision repair (BER) pathway. Previous work has implicated telomeric proteins such as the shelterin complex in mediating BER. Here we show for the first time that the CST complex and individual subunits robustly stimulate a myriad of proteins involved in the BER pathway including Pol β, APE1, FEN1, and LIGI. CST’s ability to augment these BER-associated proteins could be instrumental in promoting efficient DNA repair. Additionally, we find that CTC1 and STN1 are able to significantly enhance the polymerase activity of Pol δ and Pol α on both random-sequence and telomeric-sequence DNA substrates in vitro. What is more, we establish the ability of CST to resolve G4 structure and promote Pol δ synthesis, which we predict is a key feature of CST’s involvement in DNA replication at telomeres, which are known to form replication-inhibiting G4’s. Our results define important mechanistic insight into CST’s role in DNA replication and repair, and provide a strong foundation for future studies relating defective telomere maintenance to aging disorders and cancers which impact human health.

Telomere dysfunction is a significant source of genomic instability and contributes to the development of cancer. The multi-protein complex shelterin binds telomeric DNA to mitigate telomere dysfunction and ensure overall telomere stability. In addition to shelterin, the telomeric cap includes the telomeric repeat-containing RNA, TERRA, which associates with telomeric proteins and the telomeric DNA itself, often forming RNA:DNA hybrids or R-loops. TERRA is most abundant in cancer cells that utilize the alternative lengthening of telomeres (ALT) pathway, where it has been suggested that TERRA R-loops act as a source of replication stress at telomeric DNA that ultimately contributes to the activation of the ALT mechanism. In an effort to evaluate the effect TERRA may have on the emergence of the ALT phenotype, we sought to identify the enzyme(s) that regulate TERRA degradation in mammalian cells. Here, we leveraged an auxin-inducible degron (AID) system to identify the 5’-3’ exoribonuclease XRN2 as a direct modulator of TERRA stability in mammalian cells. Following XRN2 depletion, we demonstrate a significant increase in TERRA on chromatin in both non-ALT and ALT-positive cell lines. While the stabilization of TERRA on chromatin alone was insufficient to drive replication stress and activation of ALT in telomerase cells, depletion of XRN2 in the ALT-positive context led to a significant increase in R-loops and DNA damage signaling at telomeric DNA. Thus, increased TERRA stability alone is unlikely to activate ALT but may instead exacerbate ALT activity. Taken together, we demonstrate that XRN2 regulates TERRA stability, that defects in TERRA metabolism can alter telomere stability, and dysfunction in both factors drive telomere dysfunction in cells that rely on the ALT pathway. / 2024-08-12T00:00:00Z

No description available.

<p>The ends of eukaryote chromosomes, a region called the telomeres, plays a critical role in maintaining genome stability. With each round of mitotic division the telomeres erode until a critically short length is reached, which signals the cell to permanently stop dividing. This is recognized as a contributing factor to ageing and the onset of age related diseases. Telomere repeat binding factor 2 (TRF2), is an important telomere DNA binding protein that has an essential role in protecting telomeres from being recognized as DNA breaks, however it has also been implicated in other aspects of telomere maintenance, such as telomere replication and telomere transcription. TRF2 acts as a protein hub for the recruitment of a number of telomere associated proteins involved in telomere maintenance, and it has been shown to be heavily modified by numerous types of post-translational modification. We demonstrate that TRF2 is methylated on arginine residues in its N-terminal region by protein arginine methyltransferase 1 (PRMT1) and that this arginine methylation is important for proper telomere maintenance. We further demonstrate that methylated TRF2 is a component of the nuclear matrix and has a distinct staining pattern in senescent cells. The importance of telomeres to ageing is exemplified by previously reported observations that defects in telomere maintenance are a common characteristic to numerous premature ageing disorders. We show that the premature ageing disorder, Cockayne Syndrome has an underlying defect in telomere maintenance. Approximately 80% of Cockayne Syndrome patients have mutations in the Cockayne syndrome group B (CSB) protein. We identified a novel interaction between TRF2 and CSB. The work presented in this thesis characterizes these novel interactions and gives new insight into the function of TRF2 in telomere maintenance.</p> / Doctor of Science (PhD)

Cockayne syndrome (CS) is a rare, segmental premature aging disorder in which the majority of cases are caused by mutations in the Cockayne syndrome group B protein (CSB). CSB is a multifunctional protein implicated in DNA repair, transcription and chromatin remodeling. The results presented here demonstrate that CSB plays an important role in telomere maintenance and DSB repair. We find that CS cells accumulate telomere doublets, have increased telomere-bound TRF1, decreased TERRA levels and a defect in telomerase-dependent telomere lengthening. These results imply that CS patients may be defective in telomere maintenance. We also uncover a novel and important role of CSB in DNA DSB repair. We show that CSB facilitates HR and supresses NHEJ during S and G2 phase. We find that CSB interacts with RIF1 and is recruited by RIF1 to DSBs in S phase. At DSBs, CSB remodels the chromatin extensively, which in turn limits RIF1 recruitment and promotes BRCA1 accumulation. The chromatin remodeling activity of CSB requires not only damage-induced phosphorylation on S10 by ATM but also cell cycle-dependent phosphorylation of S158 by cyclin A-CDK2. Both modifications are needed for the intramolecular interaction of CSB N-terminal domain with its ATPase domain. This intramolecular interaction has previously been reported to regulate the ATPase activity of CSB. Taken together, these results suggest that ATM and CDK2 control of CSB to promote chromatin remodeling, which in turn inhibits RIF1 in DNA DSB repair pathway choice. / Thesis / Doctor of Philosophy (PhD)

Les télomères sont des structures nucléoprotéiques localisées aux extrémités des chromosomes. Ils jouent un rôle important dans le maintien de l’information génétique, la stabilité et la protection des extrémités chromosomiques. Les télomères sont composés de séquences d’ADN répétées riches en guanines (TTAGGG) et des protéines télomériques qui les protègent. Parmi celles-ci, TRF1 et TRF2 se fixent directement sur le double brin. Toute modification de la structure des télomères (composition en protéines télomériques, raccourcissement de leur longueur, dommages) peut entrainer la mort des cellules cancéreuses. Ainsi les télomères sont considérés comme des cibles thérapeutiques. Etant riches en guanines adjacentes, les télomères sont donc des cibles potentielles du cis-platine, agent pharmacologique utilisé dans le traitement d’un certain nombre de tumeurs. Nous avons analysé, sur deux lignées de cancer d’ovaire A2780 sensibles et résistantes au cis- platine, les modifications éventuelles de la structure de leurs télomères après traitement par le cis-platine et quantifié le cis-platine fixé au niveau des télomères afin de déterminer s’il pourrait être l’origine de ces perturbations. Suite au traitement par le cis-platine, une délocalisation de TRF2 des télomères (maximum 55%) a été mise en évidence dans les deux lignées, accompagnée de dommages au niveau des télomères (2-3 dommages/cellule) mais elle est cependant insuffisante pour induire leur raccourcissement. Ensuite, la quantification par ICP-MS du cis-platine fixé au niveau de l’ADN télomérique purifié montre que le cis-platine se fixe bien au niveau des télomères. Cependant cette quantité fixée est 5 fois moins importante que celle trouvée au niveau de l’ADN génomique et 12 fois moins importante que celle attendue d’après les études in vitro, suggérant que les guanines de l’ADN télomérique sont moins accessibles que celles de l’ADN génomique. D’autre part, la quantité de cis-platine fixé par base est trop faible pour expliquer le déplacement de TRF2. Ces résultats suggèrent que la fixation du cis-platine au niveau des télomères ne peut donc pas être le mécanisme majoritaire responsable du déplacement de TRF2 des télomères et de la mort des cellules. Ce travail ouvre ainsi la voie à la conception de nouveaux complexes anti-tumoraux de platine qui cibleraient plus spécifiquement les télomères des cellules cancéreuses afin de les déstructurer plus efficacement. / Telomeres are nucleoprotein structures located at the ends of chromosomes. They play an important role in the maintenance of the genetic information, the stability and protection of chromosome’s ends. Telomeres consist of repeated DNA sequences G-rich (TTAGGG)n, and telomeric proteins that protect them. Among them, TRF1 and TRF2 bind directly to double-stranded. Any change in the structure of telomeres (telomeric protein composition, shortening their length, damage) can cause the death of cancer cells. Thus telomeres are considered as therapeutic targets. Since they are rich in adjacent guanines, telomeres are therefore potential targets for cis-platin, a pharmacological agent used in the treatment of a certain number of tumours. We looked for, at the cellular level, using two lines of ovarian cancer A2780: sensitive and resistant to cis-platin any changes in the structure of their telomeres after cis-platin treatment. And we checked the amount of cis-platin bound to telomeres to determine if it could be the cause of these perturbations. Following treatment with cis-platin, a delocalisation of TRF2 from telomere (maximum 55%) was observed within both cell lines, with damages at telomeres (2-3 damages / cell). But it is still not enough to induce their shortening. Then, the quantification by ICP-MS of the cis-platin fixed at purified telomeric DNA, shows that cis-platin binds well at telomeres. However, this amount is 5 times less than that the one found at genomic DNA and 12 times less than the one expected from in vitro studies, suggesting that the guanines of the telomeric DNA are less accessible than those of the genomic DNA. On the other hand, the amount of cis-platin bound by base is too small to explain the displacement of TRF2. So, these results suggest that the binding of cis-platin at telomeres cannot be the principal mechanism responsible of cell death, and that the displacement of TRF2 from telomere is not related directly to this phenomenon. Thus, this work opens the way for the design of new anti-tumour platinum complexes that target telomeres of cancer cells more specifically, in order to induce more efficiently their dysfunction.

Overall, this study enhances our understanding of the role of c-Myc activation in chromosome 11 repositioning in mouse PreB v-abl/myc cells and a possible interaction between telomeres, TRF2, and lamin A/C underlying this phenomenon. Additionally, the importance of human 17q25.3 is confirmed as a potential region involved in NSCLC tumorigenesis. A utilizationof the 3D telomeric organization profiles is demonstrated a tendency to categorize NSCLC patients into different prognostic subgroups, underscoring a potential future value of its clinical application. / February 2017

Résumé : Chez la levure Saccharomyces cerevisiae, la régulation de la longueur des télomères témoigne de la compensation entre mécanismes d'érosion (exonucléases, réplication semi-conservative et résection), facteurs d’élongation (la télomérase, transcriptase inverse à l'action retrouvée dans 90% des cancers humains) et actions de diverses protéines de régulation télomérique spécifiques, conférant aux télomères leur caractère de « capuchon » protégeant les extrémités des chromosomes eucaryotes. Afin de savoir si les gènes impossibles à déléter, car essentiels à la survie cellulaire, jouent aussi un rôle sur l’homéostasie télomérique, j'ai réalisé un criblage génétique utilisant des mutants tet-off de la levure pour lesquels la sous-expression considérable d'un gène essentiel a été induite de façon conditionnelle. Ceci permet d’étudier les effets qui en résultent sur l’homéostasie des télomères. Au total, mon travail a traité plus de 662 gènes essentiels pour lesquels j'ai analysé le phénotype de longueur des télomères de manière qualitative par comparaison des télomères de souches mutées par rapport à ceux de souches de type sauvage. Puis, grâce à l’amélioration technique que j'ai mise au point, la quantification de la taille des répétitions télomériques de 300 de ces souches a déjà pu être précisément analysée. Il est notable que tous les gènes essentiels étudiés ici ont des effets très différents qui résultent en des chromosomes possédant des télomères de longueur très inégale. Pour près de 40% des mutants analysés, les tailles de télomères sont apparues critiquement différentes de celles normalement présentées par la levure, beaucoup de ces gènes essentiels étant impliqués dans des mécanismes affectant le cycle cellulaire, la réparation, etc. La majorité des gènes criblés apporte un important complément d’information dans une littérature presque inexistante sur les effets de gènes essentiels de la levure au niveau de la biologie des télomères. C’est le cas des mutations de YHR122W (montrant des télomères long) et YOR262W (télomères courts), deux gènes qui sont apparus d'après mes résultats nécessaires au maintien de l'homéostasie télomérique (prenant place dans un grand ensemble de gènes que j’ai dénommé gènes ETL pour Essential for Telomere Length Maintenance). / Abstract : In the yeast Saccharomyces cerevisiae, the regulation of telomere length reflects the offset between erosion mechanisms (exonucleases, semi-conservative replication and resection), elongating factors (via the telomerase reverse transcriptase, which is found in 90 % of human cancers) and actions of various specific telomeric regulatory proteins, which collectively confer telomeres their property of being a "Cap" that protects the ends of eukaryotic chromosomes. To determine whether essential genes that can not be suppressed also play a role in telomere homeostasis, I realized a genetic screen with yeast tet-off mut ants in which a significant under-expression of an essential gene was induced. This allows to study the resulting effects on telomere homeostasis. Overall, my work dealt with more than 662 essential genes for which I analyzed the telomere length phenotypes qualitatively by comparing telomere lengths in mutant strains to those in wild-type strains. Furthermore, via technical improvements that I developed, a quantification of the sizes of telomeric repeats from 300 of these strains was determined. It is notable that all essential genes studied here have very different effects resulting in chromosomes with very unequal lengths of telomeres. For nearly 40% of the analyzed mutants, telomeres sizes appeared to be critically different from those in wt yeast. Many of these essential genes are involved in mechanisms affecting the cell cycle, DNA replication, DNA repair, etc. The majority of genes revealed in our screen provide important additional information to an almost non-existing literature on the effects of essential genes on yeast telomere biology. This is particularly the case for underexpressing the gene YHR122W (yielding long telomeres) and YOR262W (yielding short telomeres). Both genes hence emerged from my results as necessary to maintain telomere homeostasis and collectively they are part of a large set of genes I called ETL genes for Essential for Telomere Length.

La leucémie lymphoïde chronique (LLC), hémopathie lymphoïde fréquente, se caractérise par une évolution clinique extrêmement variable. Bien que les marqueurs de pronostic soient nombreux dans la LLC, aucun n'est univoque. Dans ce contexte, identifier de nouveaux facteurs prédictifs et comprendre la pathophysiologie de marqueurs pronostiques déjà établis constituent deux objectifs importants pour améliorer la prise en chargethérapeutique de cette hémopathie. Nous avons tout d'abord choisi d'étudier la valeur pronostique et les mécanismes de régulation de l'expression du gène anti-apoptotique MCL1. Nous avons montré que l'expression de MCL1 est un marqueur prédictif de la survie globale parmi l'ensemble despatients et parmi les stades précoces ; ce marqueur est également prédictif de la survie sans traitement des patients en stade A. Ainsi, l'expression de MCL1 permet d'identifier précocement les formes de LLC à haut risque et faible risque d'évolution défavorable. Nous avons également démontré que l'expression de MCL1 est fortement corrélée à l'expression de VEGF, confirmant le rôle de cette voie de signalisation dans la survie des lymphocytes tumoraux et suggérant que VEGF pourrait réguler positivement l'expression de MCL1 selon un mode autocrine. Nous avons ensuite exploré la fonction télomérique en rapport avec les anomalies chromosomiques à valeur pronostique, reflets de l'instabilité génomique. Notre travail a contribué à démontrer la relation entre l'instabilité génomique et le statut télomérique, évalué par la longueur des télomères et l'expression de hTERT et des gènes du complexe shelterin. Nous avons ainsi mis en évidence trois groupes de patients présentant des profilscytogénétiques et télomériques distincts : le premier groupe combine une cytogénétique favorable, des télomères longs, une expression faible ou absente de hTERT et une expression forte des gènes du complexe shelterin ; le troisième groupe se caractérise par de multiples aberrations chromosomiques (notamment délétions 17p et 11q), une augmentation de l'expression de hTERT et une diminution de la longueur des télomères et des niveaux d'expression de TRF1, TRF2 et POT1 ; le deuxième groupe est intermédiaire. Ces résultats confirment l'existence d'un lien entre statut télomérique et instabilité génomique au cours de la LLC et soulignent le rôle de la perte de TP53 ou ATM dans cette dysfonction télomérique. L'altération du statut télomérique est par ailleurs associée à des caractéristiques de pronostic défavorable, comme l'absence de mutation des IgVH, l’expression de CD38 et le doublement rapide de la lymphocytose. Enfin, nous avons évalué l’intérêt de la technique de MLPA pour la mise en évidence des anomalies cytogénétiques récurrentes à valeur pronostique de la LLC. Nous avons montré qu'il existe une bonne concordance entre la technique de référence et la MLPA, qui constitue une approche rapide et peu coûteuse pour la recherche d'anomalies génomiques présentes dans une majorité de cellules malignes. Nous avons cependant mis en évidence des cas intéressants de faux-positifs et de faux-négatifs avec la MLPA, indiquant que cette méthode ne peut pas remplacer les techniques classiques, mais constitue une approche complémentaire permettant une évaluation simultanée de divers déséquilibres. / Chronic lymphocytic leukemia (CLL) is a frequent lymphoid hemopathy characterized by an extremely variable clinical course. Although there are numerous prognostic markers in CLL, none is univocal. In this context, identifying new predictive factors and understanding the pathophysiology of previously established prognostic markers represent two important aims to improve therapeutic management of this hemopathy. We first chose to study the prognostic value and mechanisms of regulation of antiapoptotic MCL1 gene expression. We showed that MCL1 expression is a predictive marker of overall survival within the whole patient cohort and among early stages; this marker is also a predictor of treatment free survival of stage A patients. Thus, MCL1 expression allows early identification of CLL forms with high risk and low risk of unfavourable evolution. We alsodemonstrated that MCL1 expression is strongly correlated to VEGF expression, confirming the role of this signalling pathway in tumour lymphocytes survival and suggesting that VEGF may be a positive autocrine regulator of MCL1 expression. We then explored telomeric function regarding prognosis-related chromosomal anomalies, reflecting genomic instability. Our work contributed to demonstrate the relationship between genomic instability and telomeric status, evaluated by telomere length and expression of hTERT and shelterin complex genes. We described three groups of patients with distinct cytogenetic and telomeric profile: first group combines good-prognosis cytogenetics, long telomeres, low or negative hTERT expression and high expression of the shelterin complex genes; third group displays multiple chromosome aberrations (particularly 17p and 11q deletions), increased hTERT expression and decreased telomere length and TRF1, TRF2 and POT1 expression levels; second group is intermediate. These results confirm the relationship between telomeric status and genomic instability in CLL and underline the role of TP53 or ATM loss in this telomeric dysfunction. The alteration of telomeric status is also associated with poor-prognosis features, such as unmutated IgVH, CD38 expression and rapid lymphocytosis doubling time. Finally, we evaluated the contribution of MLPA approach for detection of recurrent prognosis-related cytogenetic anomalies. We found a good concordance between the goldstandard technique and MLPA, which represent a time and cost-effective approach for the detection of genomic aberrations affecting most malignant cells. We however described interesting MLPA false-positive and false-negative cases, indicating that this method may not replace classic techniques, but may constitute a complementary approach allowingsimultaneous evaluation of various imbalances.

The integrity of the genome relies on the maintenance of chromosomes, the structural embodiment of the genetic material. Disruption of chromosome replication can lead to extensive genomic rearrangements, spanning kilobase (Kb) to megabase (Mb) regions. Some chromosome rearrangements are inherently dynamic, beginning as a single unstable rearrangement from which multiple rearrangements emerge. The rare formation and transient behavior of unstable chromosomes renders their study challenging. Here I characterize the genetic ontogeny of unstable chromosomes in a budding yeast model, from initial replication error to unstable chromosome formation to their resolution. I find that the initial error often arises in or near the telomere and frequently forms unstable chromosomes that later resolve to an internal "collection site" in the middle of the chromosome. The initial telomere-proximal unstable chromosome is increased in cells mutant for telomerase, the Tel1 checkpoint kinase and even the Rad9 checkpoint protein, with no known telomere-specific function. Defects in Tel1 and the Rrm3 DNA helicase, or the Tel1-MRX complex and 9-1-1 checkpoint clamp, synergize dramatically to generate unstable chromosomes, further illustrating the consequence of replication error in the telomere. I performed a candidate genetic screen of instability in telomere maintenance and DNA damage response (DDR) proteins to characterize the interplay of pathways regulating senescence and genomic instability. Collectively, my results suggest that unstable chromosomes form in or near damaged telomeres, independently of end degradation (Exo1-independent), by either nonhomologous end joining (partially Lig4-dependent) or by faulty template switch during replication (Lig4- and Rad52-independent). The telomere-proximal unstable chromosomes then rearrange further to the middle of the chromosome. These results implicate telomere replication errors as a common source of widespread genomic changes and make substantial progress to our understanding of the initiation and fate of unstable chromosomes in the eukaryotic genome.